Healthspan Capital
Overview
Healthspan Capital is a venture capital firm dedicated to investing in and supporting longevity biotechnology companies. Their mission is to accelerate the development of innovative therapies, diagnostics, and devices that extend human healthspan. By providing transparent capital, they aim to empower a community to translate cutting-edge aging research into real-world applications. The firm's investment strategy focuses on early-stage ventures in the longevity biotech sector, emphasizing areas such as cellular reprogramming, senolytic compounds, and NAD+ metabolism. They employ an open-source AI screening process to evaluate potential investments, ensuring that funds are allocated to projects with high translational readiness and scientific novelty. Healthspan Capital's approach is characterized by radical transparency, with all financial transactions and project milestones logged on a public ledger. This commitment to openness allows backers to track the progress of their investments in real time, fostering trust and accountability within the community. By bridging the gap between laboratory breakthroughs and accessible healthspan solutions, Healthspan Capital plays a pivotal role in advancing the field of longevity biotechnology.
Investment Focus
- Companies focused on longevity biotechnology and regenerative medicine
- Innovations targeting the fundamental drivers of aging
- Startups specializing in DNA repair and related areas
- Innovative longevity biotech solutions
- Transparent financial practices
- Open-source AI evaluation
Portfolio Companies
Reach Healthspan Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Healthspan Capital
What sectors does Healthspan Capital invest in?
Healthspan Capital invests in Healthcare, Life Sciences, Biotechnology, Regenerative Medicine and Longevity, and is based in California, United States. Healthspan Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Healthspan Capital invest at?
Healthspan Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Healthspan Capital invest in?
Healthspan Capital invests across United States, United Kingdom, Germany, Denmark, Switzerland and Israel.
What companies has Healthspan Capital invested in?
Healthspan Capital's portfolio includes ImmuneAge Bio, Metanoia Bio, Aspire Healthspan, Bio Atelier and Nordic Laboratories.
How do I contact Healthspan Capital?
Healthspan Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
